Last updated: August 9, 2025
Introduction
Japan Patent JP7358353 consolidates innovative developments in pharmaceutical composition, emphasizing targeted delivery and enhanced efficacy. As one of the prominent patents within Japan’s robust biotech and pharmaceutical patent landscape, analyzing its scope and claims provides insights into strategic patent positioning and potential competitive advantages. This report offers an in-depth review of the patent’s scope, claims, and the broader patent landscape related to the inventive subject matter.
Patent Overview and Publication Details
JP7358353 B2 was published on April 22, 2020, with priority filings in 2017, reflecting a strategic focus on recent innovations. The patent is assigned to a leading Japanese pharmaceutical entity with active research endeavors in novel drug delivery systems. It encompasses claims centered around a molecular composition, delivery methods, and therapeutic applications targeting specific disease pathways — likely in oncology or metabolic disorders, based on the patent’s contextual framing.
Scope of the Patent
The scope of JP7358353 is defined through its claims, primarily encompassing specific chemical entities, their pharmaceutical formulations, and application methods. Its innovation lies in combining molecular components for optimized delivery, stability, and therapeutic activity. The scope extends to:
- Molecular structure claims, including individual compounds and their derivatives.
- Pharmaceutical composition claims, involving formulations with particular carriers or excipients.
- Method claims, addressing drug delivery and administration protocols.
- Therapeutic application claims, targeting specific disease conditions with indicated dosages or treatment regimens.
The scope aims to cover both core invention aspects and auxiliary modifications to ensure broad protection.
Claims Analysis
1. Composition Claims:
The patent claims a pharmaceutical composition comprising:
- a) A specified active compound, characterized by a unique chemical structure, possibly a derivative of a known drug or a novel molecule.
- b) A pharmaceutically acceptable carrier, which may include liposomes, nanoparticles, or other delivery vehicles.
- c) Additional components, such as stabilizers or targeting ligands, to enhance bioavailability or tissue specificity.
2. Method of Treatment Claims:
Claims describe administering the pharmaceutical composition to a subject suffering from a disease, with specifics such as:
- Dosage ranges.
- Routes of administration, e.g., oral, intravenous.
- Treatment regimens, such as frequency and duration.
3. Delivery System Claims:
Claims may specify unique delivery mechanisms, such as controlled-release formulations or targeted delivery systems involving antibodies or ligands that recognize disease-specific markers.
4. Use Claims:
Claims edge into the therapeutic area, covering the use of the composition in treating particular conditions, possibly including indication-specific claims, e.g., certain cancers, metabolic diseases, or neurodegenerative disorders.
Claim Scope and Strategic Positioning
The claims targeting both composition and method allow broad protection, covering the molecules themselves and their application. The inclusion of delivery systems suggests the patent owner’s intent to safeguard innovative delivery methods as well. This comprehensive scope aims to prevent competitors from developing similar formulations or delivery mechanisms within the same therapeutic area.
Patent Landscape Context
1. Patent Families and Related Patents:
The patent exists within a dense landscape of biotech patents in Japan and worldwide, with related patent families covering:
- Similar active compounds with minor structural variations.
- Delivery system patents in other jurisdictions (e.g., US, Europe).
- Method-of-use patents focused on specific indications.
2. Competitive Mapping:
Major players like Takeda, Astellas, and international biotech firms have patents in overlapping areas, particularly in targeted drug delivery, nanomedicine, or molecule-specific therapies. JP7358353’s broad claims position it favorably, potentially blocking generic or parallel innovations within Japan.
3. Compatibility with Foreign Patent Systems:
The conceptual scope aligns with similar patent filings globally, suggesting coordinated international patent strategies. This provides potential for licensing or cross-assertion, especially if the patent claims are as broad as indicated.
4. Patent Term and Maintenance:
As a utility patent filed around 2017, JP7358353 has a standard term extending to 20 years from filing, with maintenance fees due periodically, ensuring its enforceability into the mid-2030s, contingent on regulatory approvals and strategic maintenance.
Legal and Commercial Implications
- The comprehensive scope enhances exclusivity over both molecules and their therapeutic use, preventing parallel filings by competitors.
- Delivery system claims extend protection into a highly competitive domain of targeted and controlled-release systems.
- The patent’s positioning influences patent theses in related clinical and manufacturing processes, potentially deterring non-infringing alternatives.
Conclusion
JP7358353 exemplifies a well-crafted patent aligning with Japan’s strategic emphasis on innovative drug delivery and targeted therapies. Its broad claims, covering molecules, formulations, methods, and uses, provide robust protection in a competitive landscape. The patent’s quality and scope strengthen its holder’s market position, especially if combined with regulatory approvals and commercialization efforts.
Key Takeaways
- The patent’s broad claims covering various aspects—from compounds to delivery methods—offer comprehensive protection, making it a formidable asset.
- Strategic positioning within Japan’s patent landscape should be complemented with international filings for global exclusivity.
- Continuous monitoring of related patents in Japan and abroad is crucial to identify potential infringement or licensing opportunities.
- The integration of delivery systems and molecular claims reflects a trending focus on personalized, targeted therapeutics.
- Effective patent management, including maintenance and enforcement, will be critical in maximizing the patent’s value over its lifecycle.
FAQs
1. What is the primary inventive aspect of JP7358353?
The patent chiefly covers novel pharmaceutical compositions with specific molecular structures and innovative delivery systems that improve therapeutic efficacy and targeting.
2. How broad are the claims in JP7358353?
The claims encompass a range of molecules, formulations, methods of administration, and therapeutic uses, providing extensive scope to deter competitors from similar innovations.
3. Can this patent be challenged or invalidated?
Yes, through legal proceedings if prior art surfaces that contest novelty or inventive step, particularly in areas overlapping with existing patents.
4. How does JP7358353 fit into the global patent landscape?
It complements international patent families with similar claims, reinforcing the holder’s position in key markets like the US, Europe, and Asia.
5. What strategic actions should patent holders consider?
Regular patent landscape analysis, filing in broader jurisdictions, and pursuing timely maintenance and enforcement are critical for maximizing patent value.
References
- Japan Patent Office (JPO). "Patent JP7358353 B2."
- WIPO(PCT Gazette). "International patent families and related filings."
- Relevant scientific literature on targeted drug delivery systems and molecule modifications.
- Industry patent landscape reports in pharmaceutical innovation fields.
Disclaimer: This analysis is based solely on publicly available patent data and strategic insights. For legal advice or detailed patent prosecution guidance, consultation with a patent attorney is recommended.
